Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis of lifestyle interventions for Type 2 Diabetes in West AfricaLifestyle changes lower blood sugar in West African adults with Type 2 Diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider lifestyle interventions for Type 2 Diabetes in West Africa, noting low to very low certainty of evidence.

This systematic review and meta-analysis examined the impact of lifestyle interventions on glycemic control in adults with Type 2 Diabetes across West Africa. The intervention included physical activity, dietary modification, and combined educational approaches compared to a control group. The primary outcomes assessed were fasting blood glucose and glycated hemoglobin levels.

The pooled mean difference for fasting blood glucose was -1.81 mmol/L with a 95% CI of -2.33 to -1.30 and a p-value less than 0.001. For glycated hemoglobin, the pooled mean difference was -1.044% with a 95% CI of -1.594 to -0.495 and a p-value of 0.0002. Both outcomes showed a reduction in levels.

The review identified several limitations including missing control group post-test values and the absence of a control group in two fasting blood glucose studies. Exceptionally high heterogeneity was observed for glycated hemoglobin with an I2 value of 98.08%. The certainty of evidence was low for fasting blood glucose outcomes and very low for glycated hemoglobin outcomes.

The authors highlight concerns about imprecision and inconsistency across studies. The model was saturated given the small number of studies available for meta-regression on glycated hemoglobin. Variability across studies underscores the need for more standardized and rigorously designed trials in the region. Findings from meta-regression should not be interpreted as confirmatory evidence of moderation.

Adults with Type 2 Diabetes in West Africa often struggle to find effective ways to manage their blood sugar. A new analysis looked at what happens when these adults change their habits. The review combined data from studies involving 645 participants who tried physical activity, dietary changes, or educational programs. They compared these efforts to a control group that did not receive these specific interventions.

The results showed a drop in fasting blood glucose and glycated hemoglobin levels. Glycated hemoglobin is a test that shows your average blood sugar over the past few months. The numbers suggest that these lifestyle steps helped lower blood sugar significantly in this group.

However, the certainty of this evidence is low. Some studies did not report blood sugar levels after the intervention ended. There was also a lot of variation between the different studies. Because of these gaps, the findings for glycated hemoglobin should be interpreted with caution. More standardized trials are needed in this region to confirm these results.

What this means for you:
Lifestyle changes lowered blood sugar in West African adults, but the evidence has low certainty.

Study Details

Study typeMeta analysis
Sample sizen = 645
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Type 2 Diabetes (T2D) is a growing public health burden in West Africa, yet the effectiveness of lifestyle interventions for glycemic control in this region remains unclear. This systematic review and meta-analysis evaluated the impact of lifestyle interventions on Fasting Blood Glucose (FBG) and Glycated Hemoglobin (HbA1c) levels among adults with T2D in West Africa. A systematic search of PubMed, Scopus, Africa Journals Online, and Cairn.info was conducted following PRISMA guidelines. Randomized controlled trials (RCTs) and quasi-experimental studies evaluating lifestyle interventions (physical activity, dietary modification, and combined/educational interventions) for glycemic control in adults with T2D in West Africa were included. Meta-analysis was performed via a random-effects model with restricted maximum likelihood (REML) estimation, using mean differences (MD) as the effect measure for both FBG and HbA1c outcomes. Heterogeneity was assessed via I2 statistics, and sensitivity, subgroup, and meta-regression analyses were conducted to examine potential moderators of the observed heterogeneity. Ten studies comprising 645 participants were included. Six studies reported FBG outcomes; however, two were excluded from the FBG meta-analysis due to missing control group post-test values and absence of a control group respectively, leaving four studies for pooling. A separate set of four studies contributed to the HbA1c meta-analysis. For FBG, lifestyle interventions were associated with reduction in FBG levels (pooled MD = -1.81 mmol/L, 95% CI: -2.33 to -1.30, p < 0.001), with moderate heterogeneity (I2 = 50.76%). The certainty of evidence assessed using the GRADE approach was rated as low for FBG outcomes and very low for HbA1c outcomes, reflecting concerns about imprecision and inconsistency across studies. Leave-one-out sensitivity analysis confirmed robustness of this finding, with estimates ranging from -1.707 to -2.087 mmol/L. Neither intervention duration nor sample size significantly moderated FBG effect sizes, with the model explaining approximately 15.7% of observed heterogeneity. For HbA1c, lifestyle interventions were also associated with reduction in HbA1c levels (pooled MD = -1.044%, 95% CI: -1.594 to -0.495, p = 0.0002), though heterogeneity was exceptionally high (I2 = 98.08%), limiting interpretability of the pooled estimate. Exploratory meta-regression identified intervention duration and sample size as statistically associated with HbA1c effect size, though the model was saturated given the small number of studies and findings should not be interpreted as confirmatory evidence of moderation. Conclusion: Lifestyle interventions, including supervised physical activity, dietary modification, and community-based diabetes education, were generally associated with improvements in glycemic control among adults with type 2 diabetes in West Africa. Evidence was more consistent for fasting blood glucose, while findings for HbA1c were highly heterogeneous and should be interpreted with caution. These results suggest potential benefit, but variability across studies highlights the need for more standardized and rigorously designed trials in the region.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.